Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Brazil / NCT07027566
Starting soon Phase 1

Effect of an Experimental Cannabidiol Gel on Tooth Sensitivity

NCT07027566 · tracked via the Priya Life Science Brazil tracker
Phase
Phase 1
Started
2025-07-25
Last updated
2025-06-18

Condition(s) studied

Dentin Sensitivity

Investigational drug(s) / intervention(s)

Potassium nitrate and sodium fluorideCannabidiol (CBD) Gel →Natrosol 4% Gel

Potassium nitrate and sodium fluoride: Gel with 5% potassium nitrate and 2% sodium fluoride gel of 5% potassium nitrate and 2% sodium fluoride for topical application to teeth before bleaching with hydrogen peroxide

Cannabidiol (CBD) Gel: Cannabidiol gel for teeth ( 2% cannabidiol oil) before bleaching with hydrogen peroxide

Natrosol 4% Gel: placebo gel (natrosol-based gel 4%) for topical application to teeth before bleaching with hydrogen peroxide.

Study summary

The goal of this clinical trial will be to evaluate the effect applying an experimental gel based on cannabidiol oil (CBD) on tooth sensitivity induced by tooth bleaching with 35% hydrogen peroxide (HP). Volunteers will be selected and allocated to the following groups: GP - placebo gel, GCBD - experimental cannabidiol gel and GKF - Potassium Nitrate and Sodium Fluoride Gel. In each group, the corresponding desensitizing gel will be applied to on the teeth for 10 minutes. All groups will then undergo in-office whitening treatment with 35% hydrogen peroxide. Patients will be instructed to record tooth sensitivity on a daily basis during the 21 days of follow-up. Pain intensity will be measured using a visual analog scale (VAS), while the risk of developing sensitivity will be recorded after each session of the whitening procedure, with two response option.

Eligibility

Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
No
Inclusion Criteria: * Participants must have at least 28 teeth in the cavity * Good oral and general health Exclusion Criteria: * active caries or periodontal disease * visible cracks in front teeth upper or lower * with evident malocclusion * restorations and prosthetics in teeth anterior teeth * gastroesophageal disorders * severe internal tooth discoloration (tetracycline , fluorosis or pulped teeth) * dentin exposure in anterior teeth and /or later * parafunctional habits * tooth sensitivity * whitening treatment prior to or undergoing orthodontic treatment * Furthermore, smokers, pregnant or breastfeeding women do not will be included.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Federal University of Pará School of Dentistry Belém Pará

More Universidade Federal do Para trials in Brazil

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07027566 on ClinicalTrials.gov ↗ ← All trials in Brazil